Universidad CEU Cardenal Herrera-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2018

  1. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

    The Lancet, Vol. 391, Núm. 10136, pp. 2236-2271

  2. The implied equity duration when discounting and forecasting parameters are industry specific

    Accounting and Finance, Vol. 58, pp. 179-209

2017

  1. Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6))

    The Lancet

  2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1345-1422

  3. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015

    The Lancet, Vol. 390, Núm. 10091, pp. 231-266

  4. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: An analysis from the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1423-1459

2016

  1. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    The Lancet, Vol. 388, Núm. 10053, pp. 1659-1724

  2. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    The Lancet, Vol. 388, Núm. 10053, pp. 1603-1658

  3. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    The Lancet, Vol. 388, Núm. 10053, pp. 1545-1602

  4. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

    The Lancet, Vol. 388, Núm. 10053, pp. 1459-1544

  5. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

    The Lancet, Vol. 388, Núm. 10053, pp. 1725-1774

  6. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

    The Lancet, Vol. 388, Núm. 10053, pp. 1813-1850

2014

  1. Impact of IFRS: Evidence from Spanish listed companies

    International Journal of Accounting and Information Management, Vol. 22, Núm. 2, pp. 157-172